Clinical trial
Evaluating Patients With Impaired Hepatic Function
NCT00398424 · Taiho Oncology, Inc., Industry · Completed
Key facts
| NCT number | NCT00398424 |
|---|---|
| Title | Evaluating Patients With Impaired Hepatic Function |
| Official title | A Phase I, Open-Label Study Evaluating The Pharmacokinetics of Components of S-1 Patients With Impaired Hepatic Function |
| Lead sponsor | Taiho Oncology, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Impaired Hepatic Function |
| Intervention type | Drug |
| Interventions | S-1/Cisplatin |
| Enrollment | 24 |
| Start date | Feb 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | Nov 10, 2006 |
| Last update posted | Sep 3, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: